CALL/ABBOTT LABORATORIES/160/0.1/21.06.24 Share Price

Warrant

DE000GP9XFN9

Market Closed - BOERSE MUENCHEN 11:57:24 10/05/2024 pm IST
0.002 EUR 0.00% Intraday chart for CALL/ABBOTT LABORATORIES/160/0.1/21.06.24
6 months-71.43%
Current year-50.00%
Date Price Change Volume
10/24/10 0.002 0.00% 0
09/24/09 0.002 0.00% 0
08/24/08 0.002 0.00% 0
07/24/07 0.002 0.00% 0
06/24/06 0.002 0.00% 0

Real-time BOERSE MUENCHEN

Last update May 10, 2024 at 11:57 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying ABBOTT LABORATORIES
Issuer Goldman Sachs
WKN GP9XFN
ISINDE000GP9XFN9
Date issued 21/07/2023
Strike 160 $
Maturity 21/06/2024 (41 Days)
Parity 10 : 1
Emission price 0.01
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.052
Lowest since issue 0.001
Spread 0.03
Spread %93.75%

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
104.7 USD
Average target price
126.1 USD
Spread / Average Target
+20.43%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW